chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Loss of consciousness; Dizziness; Ear discomfort; Pain; Headache; Nausea; This case was received via  VAERS on 18-May-2021 and was forwarded to Moderna on 18-May-2021.    This regulatory authority case was reported by an other health care professional and describes the occurrence of LOSS OF CONSCIOUSNESS (Loss of consciousness) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Traumatic brain injury and Dizziness. Concurrent medical conditions included Allergy to grains, Fistula (TBI w bilateral perilymph fistula causing gluten issue was reported.) and Gluten intolerance (TBI w bilateral perilymph fistula causing gluten issue was reported.). Concomitant products included VIT D [VITAMIN D NOS].   On 29-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, the patient experienced LOSS OF CONSCIOUSNESS (Loss of consciousness) (seriousness criterion medically significant), DIZZINESS (Dizziness), EAR DISCOMFORT (Ear discomfort), PAIN (Pain), HEADACHE (Headache) and NAUSEA (Nausea). At the time of the report, LOSS OF CONSCIOUSNESS (Loss of consciousness), DIZZINESS (Dizziness), EAR DISCOMFORT (Ear discomfort), PAIN (Pain), HEADACHE (Headache) and NAUSEA (Nausea) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided by the reported.  The patient received both scheduled doses of mRNA-1273 prior to the event; therefore, action taken with the drug in response to the event is not applicable.  Patient passed out 8n bathroom from lain and nausea. She could left bed till 4pm that day due to body pain, chills and headache. 72 hours later still she had left ear full, very dizzy and slight nausea.; Sender's Comments: Very limited information regarding these events has been provided at this time. The events are probably related to the patient's comorbidities, further information required.
Pt recvd Measles vax on 7NOV90 & on 15NOV90 pt devel malaise, fever, & mild lymph node adenopathy; 17NOV90 pt devel a facial rash; On 19NOV90 rash to face, torso, & extremities; t103 dx measles made; pt felt exhausted;
Combined initial and follow up report received on 01 Apr 2010. This patient was on treatment with Diovan Amlo Fix 320/5 mg, one tablet in the morning daily initiated on an unknown date for hypertension. On 09 Mar 2010, she received H1N1 vaccine and experienced urticaria and itch on the body including scalp and forearm and described it like something was poking her. She had never had this reaction before and thought that they occurred due to the vaccine, but she started the Diovan Amlo Fix coincidently. She was itching a lot, due which she hurt herself as the itch intense. As a measure, she stopped taking Diovan Amlo Fix on an unknown date. At the moment of contact she did not have any itching. The outcome was reported as recovered. The seriousness and causality were not reported. After an internal review on 14 Apr 2010 of the data received on 01 Apr 2010, H1N1 influenza virus vaccine (manufacturer and batch number unknown) was recorded and made as co-suspect.
Myalgia, Fever, muscle/body aches, fever, myalgias Narrative:
pt recv vax 22NOV96 & 27NOV96 bumpy rash noted by mom; not red or hot on baby rt hip to knee on anterior surface of leg only;pt cranky-teething;no redness or heat @ site;
I had 15 menstrual cycles from April 2021 to end of June 2021. I went to the doctor had Diagnostic ultrasound of lining and prescribed another birth control in September 2021. I also experienced pain on my right breast couldn't sleep with a bra. Both symptoms lasted to around August 2021 and haven't had a menstrual since October 2021.
This spontaneous case reported by an other healthcare professional, describes the occurrence of administered expired product (dose administrated after 24 hours punctured vial) and product storage error (vial stored for more than 24 hours after first puncture) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19  immunization. No medical history reported. On Mar 30, 2022, at 1:48 pm, patient received dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. March 2022, patient experienced product storage error (vial stored for more than 24 hours after first puncture). On Mar 30, 2022, at 1:48 pm, patient experienced administered expired product (dose administrated after 24 hours punctured vial). At the time of the report, administered expired product (dose administrated after 24 hours punctured vial) and product storage error (vial stored for more than 24 hours after first puncture) outcome: unknown. The reporter did not provide any causality assessments, concomitant medication or treatment information. Reportedly, the vial that was punctured March 29, 2022, at 1:39 pm, was administered on March 30, 2022 at 1:48 pm.
It hurt less than the flu shot and so far my arm is just a little sore; This is a spontaneous report from a Pfizer Sponsored Program Corporate (Pfizer) Social Media Platforms. Two contactable consumers (one is the patient) reported that a female patient of an unspecified age started to receive BNT162B2 (Lot number and expiry date unknown), via an unspecified route of administration from an unspecified date at single dose  for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the COVID-19 vaccine this morning and sated that it hurt less than the flu shot and so far her arm is just a little sore on an unspecified date. Stated, "Once I get my second dose I'll feel much safer at work and in public". The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
pain in the right artificial knee.; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (pain in the right artificial knee.) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     The patient's past medical history included Knee replacement since an unknown date.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced ARTHRALGIA (pain in the right artificial knee.). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form, qd. At the time of the report, ARTHRALGIA (pain in the right artificial knee.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.     Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: On 03-MAY-2021 a follow up was received which contained no new information.
I had a case of shingles. Started with rear upper thigh leg pain. It turned into a right side rash and moved all the way up to my rear - mainly the back side of my leg. It was very severe and painful. The doctor gave me Valtrex (Valacyclovir tablets), Tylenol, and Methylprednisolone. I had some relief after a week, but the rash started to scab up.
I received my second Pfizer booster for COVID-19 on 4/7/2022. On the night of 6/22/2022, I felt a tightness in my chest and used my inhaler. I knew that I had previously been exposed to COVID-19, so on 6/23/2022 I took both a rapid test and a PCR test. The rapid test yielded a negative result, but the PCR test yielded a positive result. On the afternoon of 6/23/2022, I began having a productive cough. On 6/24/2022, I called my doctor's office, and I was prescribed a 5-day course of Paxlovid, which I started that day. The coughing became very persistent, and I developed a very deep, raspy voice. On 6/25/2022, I still had a cough and was very fatigued. That evening, I had a low-grade fever for about an hour. On 6/26/2022, the symptoms were about the same. I had coughing, hoarseness, and fatigue, but no fever. On 6/27/2022, I felt better. I had more energy, and the coughing had diminished some. I was able to walk my dogs for the first time in several days. The symptoms continued to improve gradually. I would say that my symptoms were completely gone by 7/1/2022.
my nerve endings felt off; my eyes have become glassy; my vision is blurred; This spontaneous case was reported by a consumer and describes the occurrence of GLASSY EYES (my eyes have become glassy), VISION BLURRED (my vision is blurred) and NEURALGIA (my nerve endings felt off) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, the patient experienced GLASSY EYES (my eyes have become glassy) and VISION BLURRED (my vision is blurred). On an unknown date, the patient experienced NEURALGIA (my nerve endings felt off). At the time of the report, GLASSY EYES (my eyes have become glassy) and VISION BLURRED (my vision is blurred) had not resolved and NEURALGIA (my nerve endings felt off) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications was not provided by the reporter. Treatment for the events included eye drops, eye wash, and allergy pills.
Information has been received from a certified medical assistant referring to unspecified number of patients of unknown age and gender. There was no information about the patients' medical history and concurrent condition. On unknown dates these patients were vaccinated with improperly stored GARDASIL 9 (lot # L016429 with expiration date 09-AUG-2017 and lot # L016428 with expiration date 30-JUL-2017, strength, dose and route unknown) (incorrect product storage). There was no information about concomitant therapy. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Day of vaccine-1/7/21-no symptoms.  Day 2-1/8/21-started vomiting and vomited with nausea for 7 days and extreme fatigue-first ER visit on 1/14/21, second ER visit on 1/16/21-started having heart palpitations on 1/14/21 and was lightheaded and dizzy with low Blood Pressure and elevated heart rate=180. On 1/16/21-with activity heart rate jumped up to 190, and provider stated this was Inappropriate Sinus Syndrome caused by Acute Viral Response.  Is set to have a heart ablation in March 2021.
The patient reports a reaction to the shot as follows: "My throat became somewhat restricted. I took a BENADRYL and an Asthma treatment and that seemed to help. Of greater concern is that within an hour and for the next 24 hours I had severe vertigo to the point that I could not move beyond a few steps, could not watch any moving such as people or TV. I took several doses of Meclizine and had severe sinus pain (I did not have any of those symptoms prior to the shot), vertigo subsided after about 24 hours and lots and lots of sleep, but still some small vertigo on Sunday. I also had low grade headaches (not migraine). I had digestive upset as well, but blame that on the meclizine and sinus medicine I was taking to try to control my symptoms." Patient reports symptoms did completely resolve but she requested this reaction be reported.
Patient reported develop a mark on her body similar to chicken pox. She reported pain at the site and inflammation and redness around the face. This occurred 2 months after her initial shot.
Information has been received from a legal firm concerning a child who received a series of vaccinations in 1995, 1996 and 1997, which contained the mercury-based preservative thimerosal, (specific vaccines not reported). The alleged result of these vaccinations is that the pt suffered damages relating to mercury poisoning. As a result of the mercury poisoning, the pt suffered neurologic damage, which resulted in hospitalization and medical treatment, physical pain and emotional anguish, a dimunition of quality of life and life expectancy and a loss of earnings capacity. All of these alleged damages are permanent and progressive. Upon internal review, the mercury poisoning, neurologic damage, emotional anguish and physical pain were considered to be "Other Medical Events". Additional information has been requested.
PFIZER COVID VACCINE VIAL  WAS EXPIRED AT 2:07PM, VACCINE WAS ADMINISTERED FROM SAME VIAL AT 4:23PM.
Mother called on 5/21/05 to report that child had chicken pox. Exposed at school 2-3 weeks ago. Had fever on 5/20/05, T 101 oral for 24 hours. Rash started 5/21/05 on face, trunk, extremities. Many had central vesicle. These were crusted by 5/24/05. Had 40-50 spots. Not seen in office. Siblings had CP in past and mother was sure rash was same.
Information has been received from a physician concerning a 13 year old female who on 03-NOV-2008 was vaccination with a first dose of GARDASIL vaccine (lot # 659180/1758U) intramuscularly in her left arm.  The patient had irregular periods after her first dose.  The patient had regular periods for almost 1 year.  After the first dose of GARDASIL vaccine, the patient had more frequent menstruation and bleed more.  The outcome was not reported.  No further information is available.
1/30/23 I woke up with a terrible headache, a fever of 100.8 and body aches. I was also nauseous.  I took an at home COVID test which was positive. My fever went up to 102 that evening and I started taking Tylenol and EmergenC. The next day I had drainage, and I began taking Mucinex. I had a telehealth on 2/2/23 . She prescribed Prednisone and Benzonatate. She recommended I take zinc, Vitamin D3 and keep managing the symptoms.  I continued to have these symptoms for a week.  It took two weeks to test Negative for COVID, 2/13/23.
Eye pain in my left eye; Joints in my thumbs are swollen. Joints in my right knee is swollen and pain full. Reoccurring rash from my forehead to my eyes. Blurry/foggy vision. Reoccurring headache.
approximately 3 inches big with black and blue discolored skin; it was so tender it kept her from sleeping on her side at night; large, indurated swelling; large, indurated swelling at the injection site/approximately 3 inches big/the swelling was approximately the size of a golf ball; injection site "was so tender"; This spontaneous report was received from a dentist referring to a 24-year-old female patient. The patient's concomitant medications, concurrent conditions and past medical history were unknown.   On an unspecified date, the patient was vaccinated with the first dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL) (strength, dose, frequency, route were not provided), for prophylaxis. She received the first quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL) injection with no issues. On 13-DEC-2019, the patient was vaccinated with the second quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL), intramuscularly (strength, dose, frequency were not provided) for prophylaxis. The lot number and expiration date were requested but unknown to the reporter or the patient.  On 18-JAN-2020, the patient presented to the reporter's office with a large, indurated swelling at the injection site approximately of 3 inches big (vaccination site induration and vaccination site swelling), with black and blue discolored skin (skin discolouration) that was so tender (vaccination site pain) it kept her from sleeping on her side at night (insomnia). The swelling was approximately the size of a golf ball. The patient reported no acute injury to the injection site other than the injection itself. The outcome of insomnia, skin discolouration, vaccination site pain, vaccination site swelling and vaccination site induration was reported as not resolved by the time of reporting.   The causal relationship between the events and quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL) was not provided.
pt recv vax 3JUN97 & that same day pt exp numbness in the rt arm & around rt side of mouth;later the same day pt devel lt arm numbness & lt circumoral numbness that lasted briefly;pt devel h/a;rt elbow to hand numbness followed by severe h/
Son who was vaccinated, contracted COVID; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Son who was vaccinated, contracted COVID) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Son who was vaccinated, contracted COVID). At the time of the report, COVID-19 (Son who was vaccinated, contracted COVID) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitants were provided. No treatment was provided.  Company comment: This spontaneous case report concerns a male patient, with no medical history reported in this case, who experienced the non-serious AESI of COVID-19.  The event was reported to occur on an unknow date after the administration of an unknown dose of the mRNA-1273 vaccine.  It is to be noticed that no information on the patient´s vaccination schedule as well as the clinical course, diagnosis and treatment received (if required) was disclosed.  At the time of the report, the outcome was Unknown.  The rechallenge is unknown as the event happened after one dose of mRNA-1273 vaccine and since no information on schedule of administration is provided. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This spontaneous case report concerns a male patient, with no medical history reported in this case, who experienced the non-serious AESI of COVID-19.  The event was reported to occur on an unknow date after the administration of an unknown dose of the mRNA-1273 vaccine.  It is to be noticed that no information on the patient´s vaccination schedule as well as the clinical course, diagnosis and treatment received (if required) was disclosed.  At the time of the report, the outcome was Unknown.  The rechallenge is unknown as the event happened after one dose of mRNA-1273 vaccine and since no information on schedule of administration is provided. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
My chest is achy; my lungs are achy; I have a headache; I have foggy brain; my abdomen is achy; sweating profusely; I was super exhausted; random deep body pains, they would come & rapidly disappeared; body aches; sweating; weakness; difficulty sleeping; My arm was sore at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (My arm was sore at the injection site), HYPERHIDROSIS (sweating), ASTHENIA (weakness), INSOMNIA (difficulty sleeping) and PAIN (body aches) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2021, the patient experienced VACCINATION SITE PAIN (My arm was sore at the injection site). On 11-May-2021, the patient experienced HYPERHIDROSIS (sweating), ASTHENIA (weakness) and INSOMNIA (difficulty sleeping). On 12-May-2021, the patient experienced PAIN (body aches) and MYALGIA (random deep body pains, they would come & rapidly disappeared). On 13-May-2021, the patient experienced HYPERHIDROSIS (sweating profusely) and ASTHENIA (I was super exhausted). On 14-May-2021, the patient experienced CHEST PAIN (My chest is achy), PULMONARY PAIN (my lungs are achy), HEADACHE (I have a headache), FEELING ABNORMAL (I have foggy brain) and ABDOMINAL PAIN (my abdomen is achy). At the time of the report, VACCINATION SITE PAIN (My arm was sore at the injection site), HYPERHIDROSIS (sweating), ASTHENIA (weakness), INSOMNIA (difficulty sleeping), PAIN (body aches), HYPERHIDROSIS (sweating profusely), ASTHENIA (I was super exhausted), CHEST PAIN (My chest is achy), PULMONARY PAIN (my lungs are achy), HEADACHE (I have a headache), FEELING ABNORMAL (I have foggy brain), ABDOMINAL PAIN (my abdomen is achy) and MYALGIA (random deep body pains, they would come & rapidly disappeared) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant product usage were not reported by the reporter. No treatment details were added.    This case was linked to MOD-2021-132119 (Patient Link).
SICKNESS FOR 4 DAYS; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included: not in good health. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company was unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced sickness for 4 days. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of sickness for 4 days was not reported. This report was non-serious.
Redness and swelling of right deltoid began at 1400 on 01/04/2006 when child awoke from nap. None had been noted earlier. Child also had itching of area which measured 7.3 by 7.0cm. Child was afebrile with no respiratory symptoms or swelling elsewhere. Treated with Benadryl Q 6 hours. Area marked and family told to call if swelling/redness extends beyond mark.
Aggitated,   shingles out break. Welts around left arm injection site and right side of neck. Confussion,  eyes blurry. Pain in joints,  muscles and back,  nsomnia,  Random bursts of pain  everywhere,  sensitivity to light,   nueropathy in hands and feet.
A sore arm; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis.   On 13-SEP-2023, the patient received RSV vaccine. In SEP-2023, less than a day after receiving RSV vaccine, the patient experienced pain in arm (Verbatim: A sore arm).  The outcome of the pain in arm was not reported.   It was unknown if the reporter considered the pain in arm to be related to RSV vaccine.     It was unknown if the company considered the pain in arm to be related to RSV vaccine.   Additional Information: GSK receipt date: 14-Sept-2023  The case was received from the patient via (social media) interactive digital media. The patient just got the RSV vaccine one day before the vaccination and had no side effects except a sore arm.
I experienced COVID-19 on 03/03/2023. I went to see my doctor who performed a COVID-19 test to confirm I did indeed have COVID-19. My doctor prescribed Paxlovid medication and my symptoms went away in 5 days until the medicine ran out.